Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-09
2010-11-23
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S291000
Reexamination Certificate
active
07838540
ABSTRACT:
Compounds of formula (I):or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
REFERENCES:
patent: 4200750 (1980-04-01), Warner et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5534518 (1996-07-01), Henrie et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6436925 (2002-08-01), Lubisch et al.
patent: 6451794 (2002-09-01), Beswick et al.
patent: 6498166 (2002-12-01), Campbell et al.
patent: 6509361 (2003-01-01), Weier et al.
patent: 6509363 (2003-01-01), Salituro et al.
patent: 6579872 (2003-06-01), Brown et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6774127 (2004-08-01), Adams et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 7125898 (2006-10-01), Aston
patent: 7151118 (2006-12-01), Angell et al.
patent: 7166597 (2007-01-01), Alberti et al.
patent: 7166623 (2007-01-01), Angell et al.
patent: 7183297 (2007-02-01), Angell et al.
patent: 7208629 (2007-04-01), Angell et al.
patent: 7271289 (2007-09-01), Aston
patent: 7309800 (2007-12-01), Angell et al.
patent: 7384963 (2008-06-01), Angell et al.
patent: 7396843 (2008-07-01), Angell et al.
patent: 7425555 (2008-09-01), Angell et al.
patent: 7432289 (2008-10-01), Angell et al.
patent: 7514456 (2009-04-01), Aston
patent: 7572790 (2009-08-01), Aston et al.
patent: 7626055 (2009-12-01), Aston
patent: 7642276 (2010-01-01), Angell et al.
patent: 7687532 (2010-03-01), Compos et al.
patent: 7709506 (2010-05-01), Aston
patent: 2001/0011135 (2001-08-01), Reidl et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 2004/0053942 (2004-03-01), Alberti et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2004/0242868 (2004-12-01), Angell et al.
patent: 2004/0249161 (2004-12-01), Angell et al.
patent: 2004/0266839 (2004-12-01), Angell et al.
patent: 2004/0267012 (2004-12-01), Angell et al.
patent: 2005/0020540 (2005-01-01), Angell et al.
patent: 2005/0038014 (2005-02-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2005/0090491 (2005-04-01), Angell et al.
patent: 2007/0054942 (2007-03-01), Patel et al.
patent: 2007/0112046 (2007-05-01), Angell et al.
patent: 2007/0142476 (2007-06-01), Angell et al.
patent: 2007/0161673 (2007-07-01), Barker et al.
patent: 0 533 266 (1992-09-01), None
patent: 0 533 268 (1992-09-01), None
patent: 0 346 841 (2003-06-01), None
patent: 0 430 033 (2004-04-01), None
patent: 2 276 161 (1993-03-01), None
patent: 2 276 162 (1993-03-01), None
patent: 2 273 930 (1993-12-01), None
patent: 2 295 387 (1996-05-01), None
patent: WO 94/15920 (1994-07-01), None
patent: WO 95/06636 (1995-03-01), None
patent: WO 95/06644 (1995-03-01), None
patent: WO 95/11243 (1995-04-01), None
patent: WO 95/15954 (1995-06-01), None
patent: WO 95/17401 (1995-06-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 95/30675 (1995-11-01), None
patent: WO 96/31508 (1996-10-01), None
patent: WO 96/31509 (1996-10-01), None
patent: WO 97/03034 (1997-01-01), None
patent: WO 99/32463 (1999-07-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/26216 (2000-05-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 00/71510 (2000-11-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO 01/70695 (2001-09-01), None
patent: WO 01/87875 (2001-11-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/032970 (2003-04-01), None
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/093248 (2003-11-01), None
patent: WO 2004/010995 (2004-02-01), None
patent: WO 2004/089874 (2004-10-01), None
patent: WO 2004/089875 (2004-10-01), None
patent: WO 2004/089876 (2004-10-01), None
patent: WO 2005/014550 (2005-02-01), None
Boehm et al.,Expert Opinion of Therapeutic Patents, vol. 10 (1) pp. 25-37 (2000).
Boehm, et al,Journal of Medicinal Chemistry, vol. 39(20) pp. 3929-3937 (1996).
Ceccarelli et al.,European Journal of Medicinal Chemistry, vol. 33 (12) pp. 943-955 (1998).
Gabriele et al.,European Journal of Organic Chemistry, vol. 2001 (24) pp. 4607-4613 (2001).
Han et al.,Biohemica et Biophysica Acta—Molecular Cell Research, vol. 1265 (2-3) pp. 224-227 (1995.
Hanson,Expert Opinion on Therapeutic Patents, vol. 7(7) pp. 729-733 (1997).
Henry et al.,Drugs of the Future, vol. 24 (12) pp. 1345-1354 (1999).
Jiang et al,Journal of Biological Chemistry, vol. 271 (30) pp. 17920-17926 (1996).
Li et al.,Biochemical and Biophysical Research Communications, vol. 228 (2) pp. 334-340 (1996).
Liebeskind et al.,Organic Letters, vol. 4 (6) pp. 979-981 (2002).
Moreland et al.,Annals of Internal Medicine, vol. 130 (6) pp. 478-486 (1999).
Murali Dhar et al.,Bioorganic and Medicinal Chemistry Letters, vol. 12 (21) pp. 3125-3128 (2002).
Rankin et al.,British Journal of Rheumatology, vol. 34 pp. 334-342 (1995).
Salituro et al.,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Wang et al.,Journal of Biological Chemistry, vol. 272 (38) pp. 23668-23674 (1997).
U.S. Appl. No. 12/713,448, Aston, N.
U.S. Appl. No. 12/713,433, Aston, N.
Davis Zinna N
GlaxoSmithKline LLC
Riek James P.
LandOfFree
3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4210838